DYN

Q: What is the price of Dyne Therapeutics (DYN) today?

The price of Dyne Therapeutics (DYN) today is US$ 16,38, with a variation of -53.52% compared to the last year. The price of Dyne Therapeutics (DYN) started the year trading around US$ 23,56 and today it is at US$ 16,38. Follow the real-time price chart, the historical price of Dyne Therapeutics (DYN), and stock data from Ibovespa and international markets.

Q: When does Dyne Therapeutics (DYN) pay dividends?

Dyne Therapeutics (DYN) não distribuiu dividendos no último ano.

Q: Dyne Therapeutics (DYN) is it worth it?

Currently, Dyne Therapeutics (DYN) is priced at US$ 16,38, with a P/E of -3,75%, representing a deviation of -4,35% from its historical average P/E. In the last year, the stock showed a variation of -53.52% in its price and distributed US$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was -53,52%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How to buy stocks of Dyne Therapeutics (DYN)?

Investing in stocks of Dyne Therapeutics (DYN) can be done in two ways: by buying the stock no exterior. A stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much do 100 stocks of Dyne Therapeutics (DYN) yield today?

The yield of Dyne Therapeutics (DYN) was 17,67% in the last month, -53,52% in the last year and 0,00% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of US$ 0,00 in dividends, um Dividend Yield de 0,00%.If you wanted to buy 100 stocks of Dyne Therapeutics (DYN) today, the total investment would be US$ 1.638,00, based on the current price of US$ 16,38.If past performance were to repeat, the return on your investment would be:In 1 year: US$ 761,34In 5 years: US$ 1.638,00In 10 years: 1.638,00It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Dyne Therapeutics Inc.

Price

US$ 16,38

variation (12m)

-53,52%

p/l

-3,75

p/vp

2,80

DIVIDEND YIELD

0,00%

price DYN

BVMF

DYN

If you had invested

years ago

6 months

1 year

5 years

10 years

ago, today you would have

ago, today you would have:

*The figure considers the reinvestment of dividends.

Profitability of DYN

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

17,67%

3 months

81,60%

1 year

-53,52%

2 years

119,57%

5 years

0,00%

10 years

0,00%

real profitability

profitability minus inflation.

1 month

17,67%

3 months

80,93%

1 year

-55,56%

2 years

100,41%

5 years

0,00%

10 years

0,00%

Indicators DYN

check out the fundamentals of Dyne Therapeutics shares

P/E

-3,75

Sector: -3,49 Industry: -3,49

P/SALES RATIO (PSR)

Sector: -4,23 Industry: -4,23

P/BV

2,80

Sector: 1,90 Industry: 1,90

DIVIDEND YIELD (DY)

0,00%

Sector: - Industry: -

ROA

-58,52%

Sector: -63,54% Industry: -63,54%

ROE

-74,66%

Sector: -70,19% Industry: -70,19%

ROIC

-1.273,72%

Sector: -2.095,92% Industry: -2.095,92%

NET MARGIN

0,00%

Sector: -41,67% Industry: -41,67%

GROSS MARGIN

0,00%

Sector: 38,19% Industry: 38,19%

OPERATING MARGIN

0,00%

Sector: -41,04% Industry: -41,04%

P/EBITDA

-3,65

Sector: -3,69 Industry: -3,69

P/EBIT

-3,63

Sector: -3,68 Industry: -3,68

P/ASSET

2,20

Sector: 1,42 Industry: 1,42

BVPS

5,01

Sector: 1,85 Industry: 1,85

EPS

-3,74

Sector: -2,19 Industry: -2,19

EQUITY / ASSETS

0,78

Sector: 0,42 Industry: 0,42

CAGR REVENUES 5 YEARS

0,00%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

45,48%

Sector: - Industry: -

DYN indicators history

DRAG THE FRAME TO SEE MORE DATA

Stocks comparator

DRAG THE FRAME TO SEE MORE DATA

	p/l	p/vp	ROE	dy	market value	net margin
JNJ	17,99	5,85	32,50%	2,66%	US$ 458,87 B	27,75%
PFE	15,32	1,58	10,33%	6,90%	US$ 140,87 B	15,13%
ABBV	108,79	-2.966,40	-2.726,81%	2,79%	US$ 409,36 B	6,45%
NVO	15,47	9,74	62,99%	2,96%	US$ 253,17 B	34,74%
MRK	12,21	4,40	36,03%	3,77%	US$ 215,83 B	28,16%
AZN	28,13	5,85	20,79%	1,85%	US$ 262,04 B	16,23%
BMY	17,14	5,05	29,44%	5,67%	US$ 88,25 B	10,71%
GILD	20,79	7,45	35,82%	2,68%	US$ 145,89 B	24,71%
ZTS	23,71	12,62	53,20%	1,37%	US$ 62,79 B	28,00%
HALO	13,25	23,31	175,93%	0,00%	US$ 7,76 B	48,21%
REGN	13,15	1,98	15,06%	0,47%	US$ 59,29 B	31,83%
AMGN	29,90	21,01	70,29%	3,24%	US$ 156,09 B	14,67%
VRTX	28,91	6,10	21,11%	0,00%	US$ 104,80 B	31,22%
MCK	25,75	-110,60	-429,55%	0,39%	US$ 95,44 B	0,97%
CAH	26,89	-14,13	-52,54%	1,30%	US$ 37,22 B	0,60%
ADMA	16,91	8,80	52,03%	0,00%	US$ 3,50 B	43,51%
BIIB	12,13	1,22	10,08%	0,00%	US$ 21,55 B	17,46%

comparison of DYN with indexes

If you had invested (change) 2 years years ago, ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

Dividend History DYN

current DY: 0,00%

5-year average DY: 0,00%

no dividend paid in the period.

ABOUT THE COMPANY Dyne Therapeutics

Dyne Therapeutics Inc.

Average user rating I10

4.0 (1 people)

Estados Unidos

8 years

Foundation: 2017

2020

Year of debut on the stock exchange - 5 years

47

Employees

The Company Dyne Therapeutics Inc. (Estados Unidos), is listed on Nasdaq with a market value of $ 1,60 Billion, having a net worth of $ 571,45 Milhões.

With a total of 47 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.

In the last 12 months the Company had a revenue of $ -, which generated a loss in the amount of $ -426,62 Milhões.

As for its main indicators, the Company has a P/E ratio of -3,75, a P/BV ratio of 2,80 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker DYN.

Market value

US$ 1,60 Billion

Net worth

US$ 571,45 Milhões

US$ 571.450.000,00

Assets

US$ 728,99 Milhões

US$ 728.990.000,00

Total Number of Shares

114,00 Milhões

114.000.000

Average Daily Trading Volume

US$ 2,70 Milhões

US$ 2.698.535,36

Sector

Health Care

Industry

Biotechnology

DYN

DYN revenue and profits

DYN results

DRAG THE FRAME TO SEE MORE DATA

DYN cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

DYN

Dyne Therapeutics Inc.

Price

variation (12m)

p/l

p/vp

DIVIDEND YIELD

Profitability of DYN

check out the fundamentals of Dyne Therapeutics shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

If you had invested (change) 2 years years ago, ago, today you would have

current DY: 0,00%

5-year average DY: 0,00%

ABOUT THE COMPANY Dyne Therapeutics

Dyne Therapeutics Inc.

Estados Unidos

8 years

2020

47

PROFIT X PRICE DYN

DYN results

DYN cash flow

evolution of assets - DYN

DYN balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

ABBV - AbbVie

PFE - Pfizer

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

ABBV - AbbVie

PFE - Pfizer

AZN - AstraZeneca

Frequently Asked Questions